BRAF and thyroid gland carcinoma: LEN was also successfully used as a bridging therapy before BRAF-targeted treatment in ATC cases.<h4>Conclusions</h4>Initial LEN therapy rapidly alleviates airway stenosis in advanced thyroid cancer with laryngotracheal invasion, offering a non-invasive alternative to emergency procedures under careful monitoring for fistula formation.